Reumatizam, Vol. 51 No. 1, 2004.
Stručni rad
Weekly and daily intake of alendronate: comparation of tolerance in osteoporosis treatment
Davorin Šakić
; Odjel za fizikalnu medicinu i rehabilitaciju, Klinička bolnica “Dubrava”, Zagreb, Hrvatska
Olga Badovinac
; Odjel za fizikalnu medicinu i rehabilitaciju, Klinička bolnica “Dubrava”, Zagreb, Hrvatska
Alboran Delija
; Odjel za fizikalnu medicinu i rehabilitaciju, Klinička bolnica “Dubrava”, Zagreb, Hrvatska
Vjekoslava Amerl Šakić
; Privatna ordinacija opće medicine, Zagreb, Hrvatska
Sažetak
In this study we analyzed, considering complains of patients, tolerance of taking alendronate 70 mg once a week in comparison with daily intake of alendronate 10 mg. Subjects were patients that were treated for osteoporosis at Department for physical medicine and rehabilitation in Clinical hospital Dubrava. The diagnosis of osteoporosis was established by DXA densitometry. Pains in oesophagus were the main reason for ceasing of use of alondronate. According to our research patients tolerate taking alendronate 70 weekly 4,22 times better than alendronate 10 daily.
Ključne riječi
osteoporosis; alendromate; 10 mg daily dose; 70 mg weekly dose
Hrčak ID:
126027
URI
Datum izdavanja:
1.8.2004.
Posjeta: 720 *